Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06693960
EARLY_PHASE1

Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

Sponsor: Washington State University

View on ClinicalTrials.gov

Summary

The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2024-09-26

Completion Date

2025-12-31

Last Updated

2024-11-26

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

Oregano

Oil of oregano administered as a softgel (180 mg).

DRUG

Drug cocktail

Oral drug cocktail consisting of caffeine (100 mg), dextromethorphan (30 mg), losartan (25 mg), midazolam syrup (2 mg), and omeprazole (20 mg).

Locations (1)

Washington State University College of Pharmacy and Pharmaceutical Sciences

Spokane, Washington, United States